Methylamine hydrochloride

CAS No. 593-51-1

Methylamine hydrochloride( Aminomethane | Methanamine )

Catalog No. M20015 CAS No. 593-51-1

Methylamine occurs endogenously from amine catabolism and its tissue levels increase in some pathological conditions including diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methylamine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Methylamine occurs endogenously from amine catabolism and its tissue levels increase in some pathological conditions including diabetes.
  • Description
    Methylamine occurs endogenously from amine catabolism and its tissue levels increase in some pathological conditions including diabetes. Interestingly methylamine and ammonia levels are reciprocally controlled by a semicarbazide-sensitive amine oxidase activity that deaminates methylamine to formaldehyde with the production of ammonia and hydrogen peroxide. Methylamine also targets the voltage-operated neuronal potassium channels probably inducing the release of neurotransmitter(s).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Aminomethane | Methanamine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    593-51-1
  • Formula Weight
    67.52
  • Molecular Formula
    CH6ClN
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:200 mM
  • SMILES
    Cl.CN
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Pirisino R et al. Methylamine: a new endogenous modulator of neuron firing? Med Sci Monit. 2005 Aug;11(8):RA257-61.
molnova catalog
related products
  • Nogo-66 (1-40)

    Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.

  • allo -Aloeresin D

    allo-Aloeresin D is a chromone glycoside isolated from Aloe spp..

  • Monascorubrin

    Monascorubrin is purified from the mycelium of Monascus purpureus. Monascorubrin has significant antibiotic activities against Bacillus subtilis and Candida pseudotropicalis.